Oxford, UK, November 22, 2022 (Yahoo) -- Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023.
Read full article here.
Wilmington, DE, September 25, 2023 (Reuters) -- Enovis Corp (ENOV.N), a leader in orthopedic bracing, surgical implants, and footcare solutions, announced on Monday its strategic acquisition of Lima
Baltimore, MD, September 12, 2023 (Business Wire) -- Protaryx Medical, announces, David Mester, MBA, as its newly appointed Chief Executive Officer (CEO). With a remarkable career spanning more tha
Monrovia, CA, September 25, 2023 (PRNewswire) -- AcuraStem, a patient-based biotechnology company pioneering how treatments are developed for neurodegenerative diseases, announced today that it has
